Menu
Search
|

Menu

Close
X

Neptune Technologies & Bioressources Inc NEPT.OQ (NASDAQ Stock Exchange Capital Market)

3.01 USD
-0.03 (-0.99%)
As of Feb 16
chart
Previous Close 3.04
Open 3.03
Volume 113,584
3m Avg Volume 147,820
Today’s High 3.12
Today’s Low 2.95
52 Week High 3.58
52 Week Low 0.70
Shares Outstanding (mil) --
Market Capitalization (mil) --
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 1 analysts

KEY STATS

Revenue
No Data Available
FY
-
FY
-
FY
-
FY
-
EPS
No Data Available
FY
-
FY
-
FY
-
FY
-

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
34.43
Price to Sales (TTM)
vs sector
--
8.57
Price to Book (MRQ)
vs sector
--
5.14
Price to Cash Flow (TTM)
vs sector
--
25.75
Total Debt to Equity (MRQ)
vs sector
--
15.12
LT Debt to Equity (MRQ)
vs sector
--
11.85
Return on Investment (TTM)
vs sector
--
13.54
Return on Equity (TTM)
vs sector
--
14.80

EXECUTIVE LEADERSHIP

John Moretz
Chairman of the Board, Since 2017
Salary: --
Bonus: --
James Hamilton
President, Chief Executive Officer, Director, Since 2015
Salary: $24,519.00
Bonus: --
Mario Paradis
Chief Financial Officer, Since 2015
Salary: --
Bonus: --
Michel Timperio
Senior Vice President of Sales - Global Sales, Since 2013
Salary: $205,769.00
Bonus: --
Pierre Lemieux
Chief Operating Officer of Acasti, Since
Salary: $219,615.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

545 Prom du Centropolis Suite 10
LAVAL   QC   H7T 0A3

Phone: +1450.6872262

Neptune Technologies & Bioressources Inc. is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company's products include Krill-Based Nutraceutical Products, including Neptune Krill Oil (NKO), OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti. The Company's NKO is a marine oil extracted from krill (Euphasia superba). NKO consists of phospholipids, which contain omega-3 fatty acids, including eicosapentaenoic acid and docosahexaenoic acid (EPA & DHA), and antioxidants, such as astaxanthin, vitamin A and vitamin E. The Company sells OCEANO3 directly to consumers in Canada through its online platform (www.oceano3.com), under its brand name.

SPONSORED STORIES